Review: clinical management of Helicobacter pylori infection in China (Q38266432)

1 September 2017

1 reference

title

Review: clinical management of Helicobacter pylori infection in China (English)

1 reference

Helicobacter pylori infectious disease

1 September 2017

0 references

1 reference

Chuan Xie

1

1 reference

PubMed ID

25382801

1 September 2017

Nong-Hua Lu

series ordinal

2

1 reference

1 September 2017

8 November 2014

1 reference

1 September 2017

1 reference

1 September 2017

20

1 reference

1 September 2017

1

1 reference

1 September 2017

1-10

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

1 September 2017

1 reference

Helicobacter pylori and gastric cancer: factors that modulate disease risk

21 January 2018

1 reference

Helicobacter pylori treatment in the era of increasing antibiotic resistance

21 January 2018

1 reference

Differential Helicobacter pylori infection rates in two contrasting gastric cancer risk regions of South China. China Gastric Cancer Study Group.

21 January 2018

1 reference

Decreasing seroprevalence of Helicobacter pylori infection during 1993-2003 in Guangzhou, southern China.

21 January 2018

1 reference

Prevalence of Helicobacter pylori infection and identification of risk factors in rural and urban Beijing, China

21 January 2018

1 reference

Risk Factors and Prevalence of Helicobacter pylori Infection in Persistent High Incidence Area of Gastric Carcinoma in Yangzhong City

21 January 2018

1 reference

Prevalence and risk factors of Helicobacter pylori infection in Chinese maritime workers

21 January 2018

1 reference

Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection

21 January 2018

1 reference

Third Chinese National Consensus Report on the management of Helicobacter pylori infection

21 January 2018

1 reference

Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms

21 January 2018

1 reference

Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication

21 January 2018

1 reference

Helicobacter pylori: clinical management

21 January 2018

1 reference

Comparison of invasive methods and two different stool antigen tests for diagnosis of H pylori infection in patients with gastric bleeding

21 January 2018

1 reference

Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China

21 January 2018

1 reference

The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China

21 January 2018

1 reference

Resistance of Helicobacter pylori to antibiotics from 2000 to 2009 in Shanghai

21 January 2018

1 reference

Primary antibiotic resistance of Helicobacter pylori isolated from Beijing children

21 January 2018

1 reference

A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial

21 January 2018

1 reference

Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance

21 January 2018

1 reference

Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study

21 January 2018

1 reference

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication

21 January 2018

1 reference

Efficacy of bismuth-containing quadruple therapies for clarithromycin-, metronidazole-, and fluoroquinolone-resistant Helicobacter pylori infections in a prospective study

21 January 2018

1 reference

Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

21 January 2018

1 reference

Furazolidone induced oxidative DNA damage via up-regulating ROS that caused cell cycle arrest in human hepatoma G2 cells

21 January 2018

1 reference

Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread

21 January 2018

1 reference

Acute renal failure after overdose of colloidal bismuth subcitrate

21 January 2018

1 reference

Adverse events with bismuth salts for Helicobacter pylori eradication: systematic review and meta-analysis

21 January 2018

1 reference

Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy

21 January 2018

1 reference

Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.

21 January 2018

1 reference

Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.

21 January 2018

1 reference

Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

21 January 2018

1 reference

Pharmacogenetics of esomeprazole or rabeprazole-based triple therapy in Helicobacter pylori eradication in Hong Kong non-ulcer dyspepsia Chinese subjects

21 January 2018

1 reference

Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan

21 January 2018

1 reference

Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.

21 January 2018

1 reference

Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistance

21 January 2018

1 reference

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan

21 January 2018

1 reference

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection

21 January 2018

1 reference

Antibiotic susceptibility of Helicobacter pylori in central Germany and its relationship with the number of eradication therapies

21 January 2018

1 reference

Helicobacter pylori resistance rates for levofloxacin, tetracycline and rifabutin among Irish isolates at a reference centre

21 January 2018

1 reference

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis

21 January 2018

1 reference

Levofloxacin-based first-line therapy versus standard first-line therapy for Helicobacter pylori eradication: meta-analysis of randomized controlled trials

21 January 2018

1 reference

Efficacy of two levofloxacin-containing second-line therapies for Helicobacter pylori: a pilot study

21 January 2018

1 reference

Effect of fluoroquinolone resistance on 14-day levofloxacin triple and triple plus bismuth quadruple therapy

21 January 2018

1 reference

Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.

21 January 2018

1 reference

Helicobacter pylori: tailored therapy with novel sequential quadruple therapies

21 January 2018

1 reference

Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection

21 January 2018

1 reference

Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy

21 January 2018

1 reference

Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a prospective randomized study

21 January 2018

1 reference

21 January 2018

1 reference

Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12178

1 reference

1 September 2017

1 reference

PubMed ID

25382801